Solving Pharma's Quality Unit Identity Crisis: 483s and Warning Letters Point to Inadequate Quality Oversight.
| Published in: | BioPharm International Vol. 33; no. 7; pp. 37 - 38 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Published: |
MJH Life Sciences
Jul2020
|
| Online Access: | View this record in EBSCOhost |